Overview


According to FutureWise analysis the market for cell counting in 2023 is US$ 8.81 billion, and is expected to reach US$ 16.83 billion by 2031 at a CAGR of 8.4%.

Cell counting is a process used to determine the number of cells in a sample. It is an essential tool in biology and medicine used to quantify the concentration of cells in a given sample and assess cell viability. Cell counting can be performed using various techniques, including manual counting, automated counting, and flow cytometry. Manual counting involves visually counting cells under a microscope, while automated counting uses instruments that can count cells and provide more accurate and reliable results. Flow cytometry is a technique that can rapidly measure the number and properties of cells in a sample based on their fluorescence and light scattering properties.

Cell counting is used in various applications, including research, drug discovery and development, diagnostics, and treatment monitoring. In research, cell counting is used to determine cell growth rates, cell viability, and cell cycle progression. It is also used to study cell differentiation, migration, and gene expression. In drug discovery and development, cell counting is used to screen potential drug candidates and evaluate their safety and efficacy. It is also used to study drug resistance and drug-drug interactions. Cell counting is a critical tool in these applications, as accurate and reproducible results are essential for ensuring the validity of drug discovery and development assays. Cell counting monitors disease progression, evaluates treatment efficacy, and guides treatment decisions in diagnostics and treatment monitoring. For example, cell counting is used in cancer treatment to monitor tumor growth and response to therapy. Cell counting monitors viral or bacterial load in a patient's blood or other bodily fluids in infectious diseases.

FutureWise Market Research has published a report that provides an insightful analysis of Cell Counting Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

By the end of the forecast period FutureWise research analysts projects that Cell Counting Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • DANAHER CORPORATION
  • THERMO FISHER SCIENTIFIC
  • BECTON, DICKINSON AND COMPANY
  • MERCK KGAA
  • BIO-RAD LABORATORIES INC.
  • ABBOTT LABORATORIES
  • PERKINELMER, INC.
  • AGILENT TECHNOLOGIES, INC.
  • CORNING
  • TECAN
  • BOULE DIAGNOSTICS AB
  • OLYMPUS CORPORATION
  • HORIBA
  • SYSMEX CORPORATION
  • SIEMENS HEALTHINEERS AG
  • HOFFMANN-LA ROCHE AG
  • LUMINEX CORPORATION

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Cell Counting Market:

In March 2022, The complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests were included in the new BC-700 Series, which was introduced by Mindray.

The need for cell-based assays in research and diagnostics, as well as the rising incidence of infectious and chronic illnesses, have both contributed to the considerable expansion of the global cell counting market in recent years. Cell counting is an essential tool in biology and medicine for measuring the number and viability of cells in a given sample. One of the key drivers of the cell counting market is the increasing demand for cell-based assays in drug discovery and development. Cell-based assays are used to screen potential drug candidates and evaluate their safety and efficacy. The accuracy and reproducibility of cell counting are critical for ensuring the validity of these assays. Moreover, the rising incidence of infectious and chronic disorders, such as cancer, HIV, and Alzheimer's disease, is driving demand for cell counting in diagnostics and treatment monitoring. Technological advancements in cell counting instruments, such as automated cell counters, flow cytometers, and imaging systems are also driving the market. These advancements have led to increased accuracy, speed, and efficiency in cell counting, as well as improved data analysis and visualization. Another important factor driving the cell counting market is the increasing adoption of cloud-based data management and analysis solutions. These solutions enable researchers and clinicians to store, analyze, and share cell counting data more efficiently and securely.

However, the cell counting market is also facing some challenges. One of the major challenges is the high cost of cell counting instruments and reagents, which may limit their adoption, particularly in developing countries. In addition, the complexity of cell counting techniques and the need for trained personnel may limit their use in smaller research labs and clinics.

By product

  • Consumables and Accessories
    • Media, Sera, and Reagents
    • Assay Kits
    • Microplates
    • Accessories
    • Other Consumables
  • Instruments
    • Spectrophotometers
      • Single-mode Readers
      • Cytometers
    • Hematology Analyzers
      • Fully Automated Analyzers
      • Semi-automated Analyzers
    • Cell Counters
      • Automated Cell Counters
      • Hemocytometers/manual Cell Counters
    • Microscopes

By Application  

  • Research Applications
    • Cancer Research
    • Immunology Research
    • Neurology Research
    • Stem Cell Research
    • Other Research Applications  
  • Medical Applications
    • Noninvasive Prenatal Diagnosis
    • In Vitro Fertilization
    • Circulating Tumor Cell Detection
  • Industrial Applications

By End Users

  • Research Institutes
  • Hospitals and Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies and Contract Research Organizations (CROs)
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Asia-Pacific region registered the highest share in the global market in 2022 because this region is home to a large population and a growing number of research and academic institutions, which are driving demand for cell counting instruments and reagents. In addition, the region is experiencing rapid growth in the biotechnology and pharmaceutical industries, which are major consumers of cell counting products for drug discovery and development. The increasing investment in research and development activities in these industries is expected to drive the demand for cell counting instruments and reagents. China and India are the key markets for cell counting in the Asia Pacific region. Both countries have large populations and growing economies, which are driving demand for healthcare services and research activities. The governments of these countries are also increasing their investments in healthcare infrastructure and research and development activities, which is expected to further drive the demand for cell counting products.

  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly
     

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth

  • To provide with an exhaustive analysis on the Cell Counting Market By Product, By Application, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction

    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology

    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Cell Counting Market Variables, Trends and Scope

    •        1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cell Counting Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Cell Counting Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Cell Counting Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Consumables and Accessories
         1.1. Media, Sera, and Reagents
         1.2. Assay Kits
         1.3. Microplates
         1.4. Accessories
         1.5. Other Consumables
        2. Instruments
         2.1. Spectrophotometers
          2.1.1. Single-mode Readers
          2.1.2. Multi-mode Readers
         2.2. Flow Cytometers
         2.3. Hematology Analyzers
          2.3.1. Fully Automated Analyzers
          2.3.2. Semi-automated Analyzers
         2.4. Cell Counters
          2.4.1. Automated Cell Counters
          2.4.2. Hemocytometers/manual Cell Counters
         2.5. Microscopes

  • 8.   Global Cell Counting Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Research Applications
         1.1. Cancer Research
         1.2. Immunology Research
         1.3. Neurology Research
         1.4. Stem Cell Research
         1.5. Other Research Applications
        2. Medical Applications
         2.1. Noninvasive Prenatal Diagnosis
         2.2. In Vitro Fertilization
         2.3. Circulating Tumor Cell Detection
        3. Industrial Applications

  • 9.   Global Cell Counting Market, By End Users Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Research Institutes
        2. Hospitals and Diagnostic Laboratories
        3. Pharmaceutical and Biotechnology Companies and Contract Research Organizations (CROs)
        4. Other End Users

  • 10.   North America Cell Counting Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Cell Counting Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Cell Counting Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Cell Counting Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. DANAHER CORPORATION
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. THERMO FISHER SCIENTIFIC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. BECTON, DICKINSON AND COMPANY
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. MERCK KGAA
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. BIO-RAD LABORATORIES INC.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. ABBOTT LABORATORIES
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. PERKINELMER, INC.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. AGILENT TECHNOLOGIES, INC.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. CORNING
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. TECAN
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. BOULE DIAGNOSTICS AB
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. OLYMPUS CORPORATION
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. HORIBA
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. SYSMEX CORPORATION
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. SIEMENS HEALTHINEERS AG
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. F. HOFFMANN-LA ROCHE AG
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. LUMINEX CORPORATION
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11